Connect with us

China

WHO adviser: The Wuhan lab investigation was conducted by ‘Chinese authorities’

Published

on

Screen Shot 2021 02 11 at 8.54.44 AM

World Health Organization adviser Jamie Metzl revealed that the WHO’s investigation into the Wuhan Institute of Virology was conducted “by Chinese autorities,” during an interview Wednesday night on Fox News’ “The Ingraham Angle.”

The WHO announced earlier this week that the investigation had ended because investigators had found it a “very unlikely” source of the COVID-19 virus. It has been alleged that the virus may have leaked from the lab.

Such accidents, however, were dismissed by the WHO as “extremely rare.” It is the global organization’s belief that the virus was first transmitted from animal to human.

“Well, the investigation itself was very short. It was two weeks of quarantine and two weeks of meetings, but the actual investigation was done by Chinese authorities. And so, the W.H.O. investigators were basically receiving reports from the Chinese officials,” Metzl told Ingraham.

“And as I see it, the big failure is that they outlined four possible ways that COVID could have begun. One was direct bat to human. Second, bat through an animal intermediate host. Third, through shipping or some kind of frozen food from somewhere else. And four, the accidental lab leak. As you know, Laura, for more than a year, I’ve been one of the leading advocates saying we have to look very, very seriously at option four.”

“But rather than saying, alright, let’s look more deeply at all of those possibilities, the W.H.O. investigators said we should look at the first three, but not at the accidental lab leak,” Metzl said. “And I’m just miffed that this has happened and I think it’s really terrible.”

The U.S. State Department in January detailed that the Wuhan Institute of Virology was conducting dangerous research on coronaviruses and couldn’t be ruled out completely as a possible source of the virus outbreak.

In fact, the report mentioned that in the fall of 2019, researchers at the lab became sick and exhibited COVID-19-like symptoms. Further, the State Department said the lab was being operated by the Chinese military.

Follow Jennie Taer on Twitter @JennieSTaer

You may like

Continue Reading

China

China Says It’s Ready for Monkeypox and the West Isn’t

Published

on

China

As the Western press is becoming more and more concerned with monkeypox outbreaks, a recent bombshell report shows that Wuhan Institute of Virology (WIV) in China manipulated monkeypox to be more contagious in humans. This follows more evidence that the WIV had been experimenting with bat coronaviruses to increasingly infect humans.

But rather than agree to an honest investigation into the WIV and its role in spreading contagion around the world, China is once again trying to sell us an alternative reality. According to Chinese state-run media, it is China that is once again poised to be humanity’s savior and darling when it comes to fighting monkeypox, much like COVID-19. Not only that, but CCP press reporting shows evidence of China having an eerily well advanced infrastructure and gameplan to fight monkeypox. The West in contrast is not prepared, according to China.

Claim #1: China has the Wisdom to Fight Monkeypox

First, Chinese state-run media portray China as in a good position to combat monkeypox due to wisdom gleaned from combating COVID-19 and smallpox. One Global Times article noted that “[i]n the very early stage of the COVID-19 pandemic, China has taken the measures of ‘early identification, reporting, isolation, diagnosis and treatment.’ Under such guidance, China has become one of the most successful countries in the COVID fight.” Another Global Times article cites a World Health Organization official as stating that “China’s COVID-19 control measures in place and largely reduced international arrivals minimize the risks of contagion in China.” A third Global Times article, citing “experts,” claims that “China’s successful experience in eliminating smallpox would also help the country act if monkeypox enters China’s borders…”

Claim #2: Chinese Healthcare Infrastructure Is Well Prepared to Deal with Monkeypox

China is well ahead of the game in dealing with monkeypox, according to Chinese state-run media. Chinese experts “suggest preparation of testing and treatment capacities in advance” to proactively combat monkeypox, according to Global Times. And “drug research should start early so that China can still control [monkeypox] should it assume pandemic proportions,” according to China Daily.

China is apparently quite far along in this “preparation” and “research.”

There are “several” Chinese manufacturers that have already made monkeypox nucleic acid test kits, and that these “can be quickly put into mass production and on the domestic market once approved by the government,” according to a second Global Times article.  This article also states that Chinese manufacturer Liferiver Bio-Tech has a nucleic acid test that has already been ordered in China and abroad.

This same article also states that vaccine development faces “no technological problems” and a vaccine can be produced in China in a year if China’s drug administration administers “a rapid special review.” China’s CDC also has already stockpiled “millions” of doses of smallpox vaccine, produced “an emergency response technical plan on monkeypox, stocked monkeypox detection reagents, and conducted training on monkeypox nucleic acid PCR testing for provincial and municipal CDC professionals.”

Mirroring its earlier “mask diplomacy” for COVID-19, it looks like China is beginning to export its healthcare to the world to help combat monkeypox. China’s Sansure Biotech is ready to register its nucleic acid test kit for monkeypox abroad, according to Global Times. And Jiangsu Bioperfectus Technologies has already has its Monkeypox Virus Real Time PCR Kits in the international market, according to Global Times.

Claim #3: The West is Ill-Equipped to Handle Monkeypox

On the other hand, Chinese media portrays the West as ill-equipped to handle monkeypox. For example, according to one Global Times editorial, “[t]he COVID pandemic that killed more than 1 million people in the US has given a tragic lesson to the US and the West, but it still remains to be seen to what extent the US and the West learned from it.” The West’s “conspiracy theories” and “panic” contributed to the “Western countries’ poor response to COVID-19.” That CCP editorial also pontificates that “[i]t is hoped that Western countries hit by monkeypox can do a good job in responding to the outbreak. They should not misjudge the virus with outdated perceptions…”

Claim #4: Current Monkeypox spread originated from outside China

Chinese media avoids the possibility that this current monkeypox outbreak could have originated in China. One Global Times article claims that there have been no cases of monkeypox reported in China, and that China faces a threat from monkeypox due to the cases being “outside known epidemic areas of Africa.” The fact that many countries have now lifted bans against international travel is the culprit for increased risk of monkeypox transmission, according to anonymous source within the Chinese CDC as mentioned in that same article. Another Global Times article stated that China could quarantine inbound international travellers “if necessary.”

The CCP propaganda machine is at it again.  Much like it tries to portray itself as a leader in fighting COVID-19, China is beginning to run a similar propaganda campaign for monkeypox. China is using COVID-19, and increasingly now monkeypox, as vehicles to curry favor and deflect responsibility for spreading contagion around the world, and to grow markets for healthcare technology and supplies.

You may like

Continue Reading
Advertisement

Trending Now

Advertisement

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC